Loading…
Stryker is investing approximately US$400 million in UK surgical robotics developer CMR Surgical, securing an exclusive option to acquire the remaining equity. The agreement also gives Stryker exclusive US commercial agency rights for CMR's Versius surgical robotics portfolio.